Individualization of the Immunological Risk Based on Selective Biomarkers in Living-donor Renal Recipients

Clinical trial NCT03465397 · UNKNOWN

Trial details

NCT number: NCT03465397
Sponsor: ORIOL BESTARD
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Kidney Transplant Failure and Rejection

Start date: 2017-11-10
Primary completion: 2021-11-01
Enrollment: 164

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.